NCT05164003View on ClinicalTrials.gov

CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase1)

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 17, 2017

Primary Completion Date

September 29, 2017

Study Completion Date

September 29, 2017

Conditions
Muscle Spasticity
Interventions
DRUG

CORETOX®

Up to a total of 360U of the IP was allowed to be injected at three flexors; wrist, elbow and finger.

DRUG

BOTOX®

Up to a total of 360U of the comparator was allowed to be injected at three flexors; wrist, elbow and finger.

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

All Listed Sponsors
lead

Medy-Tox

INDUSTRY

NCT05164003 - CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase1) | Biotech Hunter | Biotech Hunter